SLU-PP-332 is a novel synthetic pan-agonist of the estrogen-related receptors (ERR, ERR, ERR), originally developed at Saint Louis University and characterised in recent pre-clinical literature as an exercise mimetic. It is widely studied in research models exploring mitochondrial biogenesis, fatty-acid oxidation, and metabolic endurance
The combination of CJC-1295 and Ipamorelin has emerged within scientific discourse as a compelling peptide blend, posited to influence the growth hormone-insulin-like growth factor (GH-IGF-1) axis through complementary mechanisms
Iron uptake primarily occurs via transferrin receptor 1 (TfR1)-mediated endocytosis, where transferrin-bound iron (Fe 3+ ) is reduced to Fe 2+ by six-transmembrane epithelial antigen of the prostate 3 (STEAP3) and released into the cytosol (Kawabata, 2019)
This approach can combine Sermorelins long-term wellness effects with Ipamorelins faster, performance-based benefits
Alcohol 1999
GHK-Cu Face Cream is a skin-rejuvenating topical formulation featuring GHK-Cu, a naturally occurring copper peptide complex studied for its regenerative effects on skin tone, texture, and firmness